25 XP   0   0   10

Sinco Pharms Hldg Ltd
Buy, Hold or Sell?

Let's analyse Sinco Pharms Hldg Ltd together

PenkeI guess you are interested in Sinco Pharms Hldg Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sinco Pharms Hldg Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sinco Pharms Hldg Ltd

I send you an email if I find something interesting about Sinco Pharms Hldg Ltd.

Quick analysis of Sinco Pharms Hldg Ltd (30 sec.)










What can you expect buying and holding a share of Sinco Pharms Hldg Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
HK$0.32
Expected worth in 1 year
HK$0.81
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
HK$0.49
Return On Investment
187.5%

For what price can you sell your share?

Current Price per Share
HK$0.26
Expected price per share
HK$0.221 - HK$0.295
How sure are you?
50%

1. Valuation of Sinco Pharms Hldg Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$0.26

Intrinsic Value Per Share

HK$-0.13 - HK$2.43

Total Value Per Share

HK$0.19 - HK$2.76

2. Growth of Sinco Pharms Hldg Ltd (5 min.)




Is Sinco Pharms Hldg Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$83.5m$51.8m$31.6m37.9%

How much money is Sinco Pharms Hldg Ltd making?

Current yearPrevious yearGrowGrow %
Making money$9.6m$18.6m-$9m-94.5%
Net Profit Margin3.1%6.7%--

How much money comes from the company's main activities?

3. Financial Health of Sinco Pharms Hldg Ltd (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  

What can you expect buying and holding a share of Sinco Pharms Hldg Ltd? (5 min.)

Welcome investor! Sinco Pharms Hldg Ltd's management wants to use your money to grow the business. In return you get a share of Sinco Pharms Hldg Ltd.

What can you expect buying and holding a share of Sinco Pharms Hldg Ltd?

First you should know what it really means to hold a share of Sinco Pharms Hldg Ltd. And how you can make/lose money.

Speculation

The Price per Share of Sinco Pharms Hldg Ltd is HK$0.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sinco Pharms Hldg Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sinco Pharms Hldg Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.32. Based on the TTM, the Book Value Change Per Share is HK$0.12 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sinco Pharms Hldg Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.001.8%0.001.8%0.013.5%0.000.3%0.000.2%
Usd Book Value Change Per Share0.026.0%0.026.0%0.015.5%0.001.7%0.001.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.026.0%0.026.0%0.015.5%0.001.7%0.001.6%
Usd Price Per Share0.03-0.03-0.24-0.08-0.06-
Price to Earnings Ratio7.17-7.17-26.28-13.13-11.15-
Price-to-Total Gains Ratio2.17-2.17-16.87-10.18-6.74-
Price to Book Ratio0.82-0.82-9.47-11.77-6.62-
Price-to-Total Gains Ratio2.17-2.17-16.87-10.18-6.74-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.033228
Number of shares30095
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.020.00
Usd Total Gains Per Share0.020.00
Gains per Quarter (30095 shares)468.68135.56
Gains per Year (30095 shares)1,874.71542.26
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10187518650542532
2037493740010851074
3056245615016271616
4074997490021692158
5093749365027112700
601124811240032543242
701312313115037963784
801499814990043384326
901687216865048804868
1001874718740054235410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%8.02.00.080.0%8.02.01.072.7%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%8.02.00.080.0%9.02.00.081.8%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%4.00.06.040.0%4.00.07.036.4%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%8.02.00.080.0%9.02.00.081.8%

Fundamentals of Sinco Pharms Hldg Ltd

About Sinco Pharms Hldg Ltd

Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. The company offers Octapharma, a human albumin solution for use in premature infants; Axetine, which is used for the treatment of bacterial infections, including respiratory infections, urinary tract infections, soft tissue infections, gynecological and obstetrical infections, gonorrhea, and other infections, as well as for the prevention of post-surgery infections; and Medocef that is used for the treatment of bacterial infections, such as the infections of the lower respiratory tract comprising pneumonia, urinary tract, bile duct, peritoneum, skin, soft tissue, pelvic area, and sepsis. It also provides Esafosfina, which is used for treating hypophosphatemia and chronic diseases, which include alcohol intoxication, malnutrition, and hypophosphatemic respiratory failure; Taurolite, a third generation oral cholic acid drug that is used for the treatment of gallstone diseases; and Tamifil injection for the treatment of metastatic prostate cancer, true precocious puberty, and endometriosis. In addition, the company is involved in the research, development, and sale of pharmaceutical products; provision of warehouse facilities for pharmaceutical products; research and manufacturing of aesthetic medicine; international trade activities; consultation services for medical and biological technology; and medical beauty services. The company was founded in 2011 and is headquartered in Chengdu, the People's Republic of China. Sinco Pharmaceuticals Holdings Limited is a subsidiary of Risun Investments Limited.

Fundamental data was last updated by Penke on 2024-03-28 03:22:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Sinco Pharms Hldg Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sinco Pharms Hldg Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • A Net Profit Margin of 3.1% means that $0.03 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 3.1%. The company is making a profit. +1
  • The TTM is 3.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.1%TTM3.1%0.0%
TTM3.1%YOY6.7%-3.6%
TTM3.1%5Y-2.4%+5.5%
5Y-2.4%10Y-1.2%-1.2%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1%1.9%+1.2%
TTM3.1%2.2%+0.9%
YOY6.7%2.4%+4.3%
5Y-2.4%2.2%-4.6%
10Y-1.2%2.1%-3.3%
1.1.2. Return on Assets

Shows how efficient Sinco Pharms Hldg Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • 4.9% Return on Assets means that Sinco Pharms Hldg Ltd generated $0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 4.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.9%TTM4.9%0.0%
TTM4.9%YOY11.0%-6.1%
TTM4.9%5Y-3.5%+8.4%
5Y-3.5%10Y0.3%-3.8%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9%0.8%+4.1%
TTM4.9%0.9%+4.0%
YOY11.0%0.8%+10.2%
5Y-3.5%0.9%-4.4%
10Y0.3%1.0%-0.7%
1.1.3. Return on Equity

Shows how efficient Sinco Pharms Hldg Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • 11.5% Return on Equity means Sinco Pharms Hldg Ltd generated $0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 11.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.5%TTM11.5%0.0%
TTM11.5%YOY36.0%-24.5%
TTM11.5%5Y-204.0%+215.5%
5Y-204.0%10Y-89.2%-114.8%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ11.5%2.1%+9.4%
TTM11.5%2.5%+9.0%
YOY36.0%2.2%+33.8%
5Y-204.0%2.3%-206.3%
10Y-89.2%2.4%-91.6%

1.2. Operating Efficiency of Sinco Pharms Hldg Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sinco Pharms Hldg Ltd is operating .

  • Measures how much profit Sinco Pharms Hldg Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • An Operating Margin of 4.5% means the company generated $0.04  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 4.5%. The company is operating less efficient.
  • The TTM is 4.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ4.5%TTM4.5%0.0%
TTM4.5%YOY9.5%-5.1%
TTM4.5%5Y3.3%+1.2%
5Y3.3%10Y4.3%-1.0%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5%3.1%+1.4%
TTM4.5%2.6%+1.9%
YOY9.5%3.5%+6.0%
5Y3.3%3.3%0.0%
10Y4.3%2.0%+2.3%
1.2.2. Operating Ratio

Measures how efficient Sinco Pharms Hldg Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.82 means that the operating costs are $1.82 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 1.818. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.818. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.818TTM1.8180.000
TTM1.818YOY1.723+0.095
TTM1.8185Y1.477+0.341
5Y1.47710Y1.300+0.177
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8181.369+0.449
TTM1.8181.369+0.449
YOY1.7231.413+0.310
5Y1.4771.312+0.165
10Y1.3001.210+0.090

1.3. Liquidity of Sinco Pharms Hldg Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sinco Pharms Hldg Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.29 means the company has $1.29 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 1.287. The company is just able to pay all its short-term debts.
  • The TTM is 1.287. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.287TTM1.2870.000
TTM1.287YOY1.335-0.048
TTM1.2875Y1.071+0.216
5Y1.07110Y1.039+0.032
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2871.366-0.079
TTM1.2871.418-0.131
YOY1.3351.403-0.068
5Y1.0711.408-0.337
10Y1.0391.299-0.260
1.3.2. Quick Ratio

Measures if Sinco Pharms Hldg Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • A Quick Ratio of 0.86 means the company can pay off $0.86 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 0.859. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.859. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.859TTM0.8590.000
TTM0.859YOY0.743+0.116
TTM0.8595Y0.622+0.237
5Y0.62210Y0.552+0.070
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8590.758+0.101
TTM0.8590.757+0.102
YOY0.7430.828-0.085
5Y0.6220.814-0.192
10Y0.5520.850-0.298

1.4. Solvency of Sinco Pharms Hldg Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sinco Pharms Hldg Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sinco Pharms Hldg Ltd to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.58 means that Sinco Pharms Hldg Ltd assets are financed with 57.6% credit (debt) and the remaining percentage (100% - 57.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 0.576. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.576. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.576TTM0.5760.000
TTM0.576YOY0.696-0.120
TTM0.5765Y0.809-0.233
5Y0.80910Y0.731+0.078
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5760.617-0.041
TTM0.5760.606-0.030
YOY0.6960.608+0.088
5Y0.8090.610+0.199
10Y0.7310.593+0.138
1.4.2. Debt to Equity Ratio

Measures if Sinco Pharms Hldg Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 135.9% means that company has $1.36 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sinco Pharms Hldg Ltd:

  • The MRQ is 1.359. The company is able to pay all its debts with equity. +1
  • The TTM is 1.359. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.359TTM1.3590.000
TTM1.359YOY2.288-0.929
TTM1.3595Y10.075-8.716
5Y10.07510Y6.556+3.520
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3591.698-0.339
TTM1.3591.678-0.319
YOY2.2881.752+0.536
5Y10.0751.733+8.342
10Y6.5561.738+4.818

2. Market Valuation of Sinco Pharms Hldg Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Sinco Pharms Hldg Ltd generates.

  • Above 15 is considered overpriced but always compare Sinco Pharms Hldg Ltd to the Medical Distribution industry mean.
  • A PE ratio of 7.17 means the investor is paying $7.17 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sinco Pharms Hldg Ltd:

  • The EOD is 7.032. Based on the earnings, the company is cheap. +2
  • The MRQ is 7.167. Based on the earnings, the company is cheap. +2
  • The TTM is 7.167. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.032MRQ7.167-0.135
MRQ7.167TTM7.1670.000
TTM7.167YOY26.285-19.118
TTM7.1675Y13.129-5.962
5Y13.12910Y11.152+1.977
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD7.03213.469-6.437
MRQ7.16714.623-7.456
TTM7.16718.845-11.678
YOY26.28518.249+8.036
5Y13.12917.230-4.101
10Y11.15219.682-8.530
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sinco Pharms Hldg Ltd:

  • The EOD is 21.816. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 22.235. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 22.235. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD21.816MRQ22.235-0.420
MRQ22.235TTM22.2350.000
TTM22.235YOY12.582+9.653
TTM22.2355Y10.723+11.512
5Y10.72310Y2.533+8.190
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD21.8166.142+15.674
MRQ22.2354.510+17.725
TTM22.2357.516+14.719
YOY12.5825.244+7.338
5Y10.7232.484+8.239
10Y2.5331.762+0.771
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sinco Pharms Hldg Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 0.82 means the investor is paying $0.82 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Sinco Pharms Hldg Ltd:

  • The EOD is 0.809. Based on the equity, the company is cheap. +2
  • The MRQ is 0.825. Based on the equity, the company is cheap. +2
  • The TTM is 0.825. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.809MRQ0.825-0.016
MRQ0.825TTM0.8250.000
TTM0.825YOY9.471-8.647
TTM0.8255Y11.774-10.949
5Y11.77410Y6.622+5.151
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD0.8091.132-0.323
MRQ0.8251.178-0.353
TTM0.8251.224-0.399
YOY9.4711.307+8.164
5Y11.7741.386+10.388
10Y6.6222.166+4.456
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sinco Pharms Hldg Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1220.1220%0.112+9%0.035+246%0.032+282%
Book Value Per Share--0.3210.3210%0.200+61%0.129+149%0.123+162%
Current Ratio--1.2871.2870%1.335-4%1.071+20%1.039+24%
Debt To Asset Ratio--0.5760.5760%0.696-17%0.809-29%0.731-21%
Debt To Equity Ratio--1.3591.3590%2.288-41%10.075-87%6.556-79%
Dividend Per Share----0%-0%-0%0.001-100%
Eps--0.0370.0370%0.072-49%0.007+435%0.004+839%
Free Cash Flow Per Share--0.0120.0120%0.150-92%0.065-82%0.016-23%
Free Cash Flow To Equity Per Share--0.0310.0310%0.099-69%0.033-8%0.030+2%
Gross Profit Margin--1.0001.0000%1.0000%0.039+2469%0.494+102%
Intrinsic Value_10Y_max--2.434--------
Intrinsic Value_10Y_min---0.131--------
Intrinsic Value_1Y_max--0.107--------
Intrinsic Value_1Y_min--0.046--------
Intrinsic Value_3Y_max--0.427--------
Intrinsic Value_3Y_min--0.088--------
Intrinsic Value_5Y_max--0.872--------
Intrinsic Value_5Y_min--0.074--------
Market Cap528551395.840-2%538716006.350538716006.3500%3842162069.760-86%1292918061.942-58%908701838.907-41%
Net Profit Margin--0.0310.0310%0.067-54%-0.024+179%-0.012+140%
Operating Margin--0.0450.0450%0.095-53%0.033+36%0.043+4%
Operating Ratio--1.8181.8180%1.723+5%1.477+23%1.300+40%
Pb Ratio0.809-2%0.8250.8250%9.471-91%11.774-93%6.622-88%
Pe Ratio7.032-2%7.1677.1670%26.285-73%13.129-45%11.152-36%
Price Per Share0.260-2%0.2650.2650%1.890-86%0.636-58%0.447-41%
Price To Free Cash Flow Ratio21.816-2%22.23522.2350%12.582+77%10.723+107%2.533+778%
Price To Total Gains Ratio2.134-2%2.1752.1750%16.871-87%10.178-79%6.744-68%
Quick Ratio--0.8590.8590%0.743+16%0.622+38%0.552+56%
Return On Assets--0.0490.0490%0.110-55%-0.035+172%0.003+1792%
Return On Equity--0.1150.1150%0.360-68%-2.040+1873%-0.892+876%
Total Gains Per Share--0.1220.1220%0.112+9%0.035+246%0.033+271%
Usd Book Value--83502598.55383502598.5530%51843877.169+61%33507911.772+149%31902503.191+162%
Usd Book Value Change Per Share--0.0160.0160%0.014+9%0.005+246%0.004+282%
Usd Book Value Per Share--0.0410.0410%0.026+61%0.016+149%0.016+162%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Eps--0.0050.0050%0.009-49%0.001+435%0.001+839%
Usd Free Cash Flow--3096366.3883096366.3880%39024726.712-92%16944661.078-82%3635277.964-15%
Usd Free Cash Flow Per Share--0.0020.0020%0.019-92%0.008-82%0.002-23%
Usd Free Cash Flow To Equity Per Share--0.0040.0040%0.013-69%0.004-8%0.004+2%
Usd Market Cap67548868.388-2%68847905.61268847905.6120%491028312.515-86%165234928.316-58%116132095.012-41%
Usd Price Per Share0.033-2%0.0340.0340%0.242-86%0.081-58%0.057-41%
Usd Profit--9606065.3009606065.3000%18680949.568-49%1796860.552+435%1022768.955+839%
Usd Revenue--314131832.632314131832.6320%279911383.201+12%234398088.653+34%175893746.220+79%
Usd Total Gains Per Share--0.0160.0160%0.014+9%0.005+246%0.004+271%
 EOD+4 -4MRQTTM+0 -0YOY+14 -195Y+23 -1110Y+25 -11

3.2. Fundamental Score

Let's check the fundamental score of Sinco Pharms Hldg Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-157.032
Price to Book Ratio (EOD)Between0-10.809
Net Profit Margin (MRQ)Greater than00.031
Operating Margin (MRQ)Greater than00.045
Quick Ratio (MRQ)Greater than10.859
Current Ratio (MRQ)Greater than11.287
Debt to Asset Ratio (MRQ)Less than10.576
Debt to Equity Ratio (MRQ)Less than11.359
Return on Equity (MRQ)Greater than0.150.115
Return on Assets (MRQ)Greater than0.050.049
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Sinco Pharms Hldg Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.939
Ma 20Greater thanMa 500.254
Ma 50Greater thanMa 1000.258
Ma 100Greater thanMa 2000.259
OpenGreater thanClose0.260
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,424,333
Total Liabilities820,521
Total Stockholder Equity603,812
 As reported
Total Liabilities 820,521
Total Stockholder Equity+ 603,812
Total Assets = 1,424,333

Assets

Total Assets1,424,333
Total Current Assets1,017,406
Long-term Assets406,927
Total Current Assets
Cash And Cash Equivalents 329,144
Net Receivables 350,162
Inventory 89,584
Other Current Assets 209,673
Total Current Assets  (as reported)1,017,406
Total Current Assets  (calculated)978,563
+/- 38,843
Long-term Assets
Property Plant Equipment 315,839
Goodwill 66,536
Intangible Assets 15,001
Other Assets 9,551
Long-term Assets  (as reported)406,927
Long-term Assets  (calculated)406,927
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities790,585
Long-term Liabilities29,936
Total Stockholder Equity603,812
Total Current Liabilities
Short-term Debt 180,806
Short Long Term Debt 180,806
Accounts payable 407,988
Other Current Liabilities 112,685
Total Current Liabilities  (as reported)790,585
Total Current Liabilities  (calculated)882,285
+/- 91,700
Long-term Liabilities
Long term Debt Total 8,608
Long term Debt 922
Capital Lease Obligations 10,684
Long-term Liabilities  (as reported)29,936
Long-term Liabilities  (calculated)20,214
+/- 9,722
Total Stockholder Equity
Common Stock164
Retained Earnings 74,173
Capital Surplus 525,225
Total Stockholder Equity (as reported)603,812
Total Stockholder Equity (calculated)599,562
+/- 4,250
Other
Capital Stock164
Cash And Equivalents329,144
Cash and Short Term Investments 329,144
Common Stock Shares Outstanding 2,032,891
Liabilities and Stockholders Equity 1,424,333
Net Invested Capital 785,540
Net Tangible Assets 522,275
Net Working Capital 226,821
Property Plant and Equipment Gross 373,764



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
122,766
376,845
441,214
464,216
787,727
819,219
611,762
764,125
1,252,053
1,232,766
1,424,333
1,424,3331,232,7661,252,053764,125611,762819,219787,727464,216441,214376,845122,766
   > Total Current Assets 
0
273,193
288,092
218,963
490,071
550,633
386,085
554,527
1,005,727
968,977
1,017,406
1,017,406968,9771,005,727554,527386,085550,633490,071218,963288,092273,1930
       Cash And Cash Equivalents 
26,679
27,851
58,280
38,138
102,050
22,710
80,330
219,755
143,765
326,052
329,144
329,144326,052143,765219,75580,33022,710102,05038,13858,28027,85126,679
       Short-term Investments 
3,390
16,604
11,936
1,158
111,407
1,818
16,154
1,990
0
0
0
0001,99016,1541,818111,4071,15811,93616,6043,390
       Net Receivables 
1,095
37,294
101,592
98,443
57,903
96,515
39,858
56,895
587,202
213,235
350,162
350,162213,235587,20256,89539,85896,51557,90398,443101,59237,2941,095
       Inventory 
0
149,085
100,676
46,563
137,602
291,193
214,806
250,963
242,561
62,762
89,584
89,58462,762242,561250,963214,806291,193137,60246,563100,676149,0850
   > Long-term Assets 
0
0
0
0
297,656
268,586
225,677
209,598
246,326
263,789
406,927
406,927263,789246,326209,598225,677268,586297,6560000
       Property Plant Equipment 
9,837
58,844
100,094
96,922
103,712
191,767
181,809
198,034
238,183
256,261
315,839
315,839256,261238,183198,034181,809191,767103,71296,922100,09458,8449,837
       Goodwill 
0
0
0
35,526
58,632
23,701
0
0
0
0
66,536
66,536000023,70158,63235,526000
       Intangible Assets 
0
0
0
40,378
32,454
223
113
45
22
0
15,001
15,0010224511322332,45440,378000
       Other Assets 
0
44,808
53,028
72,427
102,858
52,895
43,755
11,519
8,121
7,528
9,551
9,5517,5288,12111,51943,75552,895102,85872,42753,02844,8080
> Total Liabilities 
117,697
328,489
317,729
270,662
330,452
546,489
589,039
718,487
1,087,624
857,880
820,521
820,521857,8801,087,624718,487589,039546,489330,452270,662317,729328,489117,697
   > Total Current Liabilities 
117,697
328,489
317,729
270,662
330,452
546,489
589,039
522,371
990,793
725,636
790,585
790,585725,636990,793522,371589,039546,489330,452270,662317,729328,489117,697
       Short-term Debt 
0
62,915
92,015
81,915
111,407
409,671
145,000
1,990
77,986
207,514
180,806
180,806207,51477,9861,990145,000409,671111,40781,91592,01562,9150
       Short Long Term Debt 
0
62,915
92,015
81,915
165,000
409,671
145,000
187,484
77,986
208,320
180,806
180,806208,32077,986187,484145,000409,671165,00081,91592,01562,9150
       Accounts payable 
0
7,546
18,637
62,793
45,832
22,522
106,901
146,158
700,320
422,933
407,988
407,988422,933700,320146,158106,90122,52245,83262,79318,6377,5460
       Other Current Liabilities 
81,297
258,028
207,077
123,169
116,733
81,783
296,839
144,013
84,452
76,508
112,685
112,68576,50884,452144,013296,83981,783116,733123,169207,077258,02881,297
   > Long-term Liabilities 
0
0
0
0
0
0
0
196,116
96,831
132,244
29,936
29,936132,24496,831196,1160000000
       Long term Debt Total 
0
0
0
0
0
0
0
154
3,409
132,244
8,608
8,608132,2443,4091540000000
       Other Liabilities 
0
0
0
0
0
0
0
195,962
93,422
0
0
0093,422195,9620000000
> Total Stockholder Equity
4,308
40,847
105,214
193,428
458,179
273,635
23,629
47,200
165,337
374,886
603,812
603,812374,886165,33747,20023,629273,635458,179193,428105,21440,8474,308
   Common Stock
0
0
0
95
130
130
136
136
136
151
164
16415113613613613013095000
   Retained Earnings 
16
36,555
89,832
159,250
175,398
-10,522
-291,300
-270,588
-135,082
478
74,173
74,173478-135,082-270,588-291,300-10,522175,398159,25089,83236,55516
   Capital Surplus 
0
0
0
14,533
258,887
258,887
289,113
289,113
289,113
365,774
525,225
525,225365,774289,113289,113289,113258,887258,88714,533000
   Treasury Stock00000000000
   Other Stockholders Equity 
0
42
42
4,014
5,009
6,361
6,901
6,920
6,920
4,233
0
04,2336,9206,9206,9016,3615,0094,01442420



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue2,271,505
Cost of Revenue-1,965,637
Gross Profit305,868305,868
 
Operating Income (+$)
Gross Profit305,868
Operating Expense-2,164,034
Operating Income117,625-1,858,166
 
Operating Expense (+$)
Research Development-
Selling General Administrative204,365
Selling And Marketing Expenses-
Operating Expense2,164,034204,365
 
Net Interest Income (+$)
Interest Income13,813
Interest Expense-18,402
Other Finance Cost-11,322
Net Interest Income-15,911
 
Pretax Income (+$)
Operating Income117,625
Net Interest Income-15,911
Other Non-Operating Income Expenses-
Income Before Tax (EBT)99,292117,625
EBIT - interestExpense = 82,822
69,462
87,864
Interest Expense18,402
Earnings Before Interest and Taxes (EBIT)101,224117,694
Earnings Before Interest and Taxes (EBITDA)124,461
 
After tax Income (+$)
Income Before Tax99,292
Tax Provision-29,830
Net Income From Continuing Ops69,46269,462
Net Income69,462
Net Income Applicable To Common Shares69,462
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-15,911
 

Technical Analysis of Sinco Pharms Hldg Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sinco Pharms Hldg Ltd. The general trend of Sinco Pharms Hldg Ltd is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sinco Pharms Hldg Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sinco Pharms Hldg Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.295 < 0.295 < 0.295.

The bearish price targets are: 0.225 > 0.222 > 0.221.

Tweet this
Sinco Pharms Hldg Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sinco Pharms Hldg Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sinco Pharms Hldg Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sinco Pharms Hldg Ltd. The current macd is 0.00089139.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sinco Pharms Hldg Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Sinco Pharms Hldg Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Sinco Pharms Hldg Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sinco Pharms Hldg Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSinco Pharms Hldg Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sinco Pharms Hldg Ltd. The current adx is 13.02.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Sinco Pharms Hldg Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Sinco Pharms Hldg Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sinco Pharms Hldg Ltd. The current sar is 0.21723418.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Sinco Pharms Hldg Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sinco Pharms Hldg Ltd. The current rsi is 51.94. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Sinco Pharms Hldg Ltd Daily Relative Strength Index (RSI) ChartSinco Pharms Hldg Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sinco Pharms Hldg Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sinco Pharms Hldg Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Sinco Pharms Hldg Ltd Daily Stochastic Oscillator ChartSinco Pharms Hldg Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sinco Pharms Hldg Ltd. The current cci is 42.88.

Sinco Pharms Hldg Ltd Daily Commodity Channel Index (CCI) ChartSinco Pharms Hldg Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sinco Pharms Hldg Ltd. The current cmo is 6.10301038.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sinco Pharms Hldg Ltd Daily Chande Momentum Oscillator (CMO) ChartSinco Pharms Hldg Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sinco Pharms Hldg Ltd. The current willr is -55.55555556.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sinco Pharms Hldg Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Sinco Pharms Hldg Ltd Daily Williams %R ChartSinco Pharms Hldg Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sinco Pharms Hldg Ltd.

Sinco Pharms Hldg Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sinco Pharms Hldg Ltd. The current atr is 0.01224391.

Sinco Pharms Hldg Ltd Daily Average True Range (ATR) ChartSinco Pharms Hldg Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sinco Pharms Hldg Ltd. The current obv is -335,148,500.

Sinco Pharms Hldg Ltd Daily On-Balance Volume (OBV) ChartSinco Pharms Hldg Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sinco Pharms Hldg Ltd. The current mfi is 40.91.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Sinco Pharms Hldg Ltd Daily Money Flow Index (MFI) ChartSinco Pharms Hldg Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sinco Pharms Hldg Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Sinco Pharms Hldg Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sinco Pharms Hldg Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.939
Ma 20Greater thanMa 500.254
Ma 50Greater thanMa 1000.258
Ma 100Greater thanMa 2000.259
OpenGreater thanClose0.260
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sinco Pharms Hldg Ltd with someone you think should read this too:
  • Are you bullish or bearish on Sinco Pharms Hldg Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sinco Pharms Hldg Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sinco Pharms Hldg Ltd

I send you an email if I find something interesting about Sinco Pharms Hldg Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Sinco Pharms Hldg Ltd.

Receive notifications about Sinco Pharms Hldg Ltd in your mailbox!